西酞普兰USP相关物质F结构式
|
常用名 | 西酞普兰USP相关物质F | 英文名 | 2-(3,3-diphenylpropyl)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine |
|---|---|---|---|---|
| CAS号 | 55011-89-7 | 分子量 | 334.49800 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C23H30N2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A | |
| 符号 |
GHS06 |
信号词 | Danger |
| 中文名 | 西酞普兰USP相关物质F |
|---|---|
| 英文名 | 2-(3,3-diphenylpropyl)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine |
| 英文别名 | 更多 |
| 分子式 | C23H30N2 |
|---|---|
| 分子量 | 334.49800 |
| 精确质量 | 334.24100 |
| PSA | 6.48000 |
| LogP | 4.25450 |
|
Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.
Eur. J. Clin. Pharmacol. 19(3) , 217-23, (1981) The pharmacokinetic constants and rectal bioavailability of the narcotic analgesic ketobemidone were determined in six male patients after surgery. Plasma concentrations were measured following intrav... |
|
|
The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene.
Pharmacol. Toxicol. 79(2) , 103-4, (1996)
|
|
|
Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene (A29) is more potent at NMDA receptors than ketobemidone alone: evidence for A29 as a non-competitive NMDA receptor antagonist.
Pharmacol. Toxicol. 82(3) , 157-60, (1998) The opioid, ketobemidone, has previously been shown to be a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. In Denmark, ketobemidone is available in a formulation which contains ketob... |
| Octahydro-2-(3,3-diphenylpropyl)-2H-pyrido(1,2-a)pyrazine |
| 2-(3,3-diphenylpropyl)octahydro-2h-pyrido[1,2-a]pyrazine |
| 2H-Pyrido(1,2-a)pyrazine,octahydro-2-(3,3-diphenylpropyl) |
| N,N,1-Trimethyl-3,3-diphenylallylamine Hydrochloride |
